Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07135037

Comparison Between Treatments of Oligohydramnios

Efficacy of L- Arginine Versus Sildenafil in Management of Idiopathic Oligohydramnios

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Kafrelsheikh University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Based on previous studies, Both sildenafil and L-arginine helped to improve idiopathic oligohydramnios. In this study, Level of improvment of oligohydramnios will be compared. As well as, NICU admission to neonates of pregnancies complicated by idiopathic oligohydramnios. The end goal is to help physicians use the best drug for their patients.

Conditions

Interventions

TypeNameDescription
DRUGSildenafil 25 MGSildenafil is a vasodilator drug which improve blood supply to placenta.Therefore, it should improve idiopathic oligohydramnios.
DRUGL-Arginine, 1000 Mg Oral TabletAminoacid with vasodilator property which improve blood supply to placenta.Therefore, it should improve idiopathic oligohydramnios.

Timeline

Start date
2024-09-01
Primary completion
2025-09-15
Completion
2025-12-31
First posted
2025-08-21
Last updated
2025-08-21

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07135037. Inclusion in this directory is not an endorsement.